Trials / Terminated
TerminatedNCT04139330
NPC-06 to Acute Pain in Herpes Zoster
A Multicenter, Double-blind, Randomized, Placebo-controlled Parallel Group Trial to Investigate the Proof of Concept of NPC-06 to Acute Pain in Herpes Zoster
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Nobelpharma · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to investigate the efficiency of pain relief and the safety of NPC-06 for the acute pain in herpes zoster in the placebo-controlled double-blind parallel group trial, in addition to explore the effective concentration of NPC-06.
Detailed description
The eligible patients will be randomized into three groups, and will receive single doses of NPC-06 (high dose and low dose) or placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NPC-06 | Infuse NPC-06 intravenously |
Timeline
- Start date
- 2019-11-21
- Primary completion
- 2021-02-28
- Completion
- 2021-02-28
- First posted
- 2019-10-25
- Last updated
- 2021-07-01
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04139330. Inclusion in this directory is not an endorsement.